RAMELLA, SARA
RAMELLA, SARA
Facoltà Dipartimentale di Medicina e Chirurgia
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up
2020-01-01 D'Angelillo, Rm; Fiore, M; Trodella, Le; Sciuto, R; Ippolito, E; Carnevale, A; Iurato, A; Miele, M; Trecca, P; Trodella, L; Greco, C; Ramella, S
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis
2021-01-01 Ramella, S.; Quattrocchi, C. C.; Ippolito, E.; Giordano, F. M.; Greco, C.; Mallio, C. A.; Santo, B.; D'Alessio, P.; Fiore, M.; D'Angelillo, R. M.; Zobel, B. Beomonte
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients
2014-01-01 Ramella, S; Spoto, S; Fiore, M; Grasso, G; Campanale, Re; Ippolito, E; Greco, C; Iurato, A; Trodella, Le; Cortigiani, M; Trodella, L; D'Angelillo, Rm; Costantino, S
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer
2020-01-01 Fiore, M; Taralli, S; Trecca, P; Scolozzi, V; Marinelli, L; Triumbari, Eka; Caputo, D; Angeletti, S; Ciccozzi, M; Coppola, A; Greco, C; Ippolito, E; Calcagni, Ml; Coppola, R; Ramella, S
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.
2016-01-01 Arcangeli, S; Ramella, S; De Bari, B; Franco, P; Alongi, F; D'Angelillo, Rm.
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer
2022-01-01 Caruso, C. M.; Guarrasi, V.; Cordelli, E.; Sicilia, R.; Gentile, S.; Messina, L.; Fiore, M.; Piccolo, C.; Beomonte Zobel, B.; Iannello, G.; Ramella, S.; Soda, P.
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation
2016-01-01 Stimato, G; Ippolito, E; Silipigni, S; DI VENANZIO, C; Rinaldi, Cg; Gaudino, D; Fiore, M; Trodella, L; D’Angelillo, R; Ramella, S
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients
2018-01-01 Ramella, S; Fiore, M; Greco, C; Cordelli, C; Sicilia, R; Merone, M; Molfese, E; Miele, M; Cornacchione, P; Ippolito, E; Iannello, G; D’Angelillo, Rm; Soda, P
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy
2010-01-01 Ramella, S; Trodella, L; Mineo, Tc; Pompeo, E; Stimato, G; Gaudino, D; Valentini, V; Cellini, F; Ciresa, M; Fiore, M; Piermattei, A; Russo, P; Cesario, A; D'Angelillo, Rm
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial
2002-01-01 Trodella, L; Granone, P; Valente, S; Valentini, V; Balducci, M; Mantini, G; Turriziani, A; Margaritora, S; Cesario, A; Ramella, S; Corbo, Gm; D'Angelillo, Rm; Fontana, A; Galetta, D; Cellini, N
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal
2007-01-01 Piermattei, A; Fidanzio, A; Azario, L; Grimaldi, L; D'Onofrio, G; Cilla, S; Stimato, G; Gaudino, D; Ramella, S; D'Angelillo, R; Cellini, F; Trodella, L; Russo, A; Iadanza, L; Zucca, S; Fusco, V; DI NAPOLI, N; Gambacorta, Ma; Balducci, M; Cellini, N; Deodato, F; Macchia, G; Morganti, Ag
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?
2018-01-01 D'Angelillo, Rm1; Ramella, S
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer
2004-01-01 D'Angelillo, Rm; Trodella, L; Ramella, S
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis
2010-01-01 Ramella, S; Trodella, L; Mineo, Tc; Pompeo, E; Gambacorta, Ma; Cellini, F; Ciresa, M; Fiore, M; Greco, C; Gaudino, D; Stimato, G; Piermattei, A; Cesario, A; D'Angelillo, Rm
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).
2018-01-01 Imbimbo, M1; Ottaviano, M2; Vitali, M3; Fabbri, A4; Leuzzi, G5; Fiore, M6; Franceschini, D7; Pasello, G8; Perrino, M9; Schiavon, M10; Pruneri, G4; Dei Tos, Ap11; Sangalli, C12; Garassino, Mc3; Berardi, R13; Alessi, A14; Calareso, G15; Petrini, I16; Scorsetti, M17; Scotti, V18; Rosso, L19; Rea, F10; Pastorino, U5; Casali, Pg20; Ramella, S; Ricardi, U21; Abate-Daga, L22; Torri, V23; Trama, A24; Palmieri, G2; Marino, M25; Zucali, Pa9; TYME network, Collaborators.
Bisphosphonates: molecular bases and clinical evidences
2011-01-01 Orecchia, R; Ramella, S; Mandoliti, G; Trodella, L; Muto, P
Breakthrough pain management in patients undergoing radiotherapy: a national survey on behalf of the Palliative and Supportive Care Study Group.
2015-01-01 Caravatta, L; Ramella, S; Melano, A; Trippa, F; Santacaterina, A; Bacchiddu, S; Mandoliti, G; Mantini, G
Can we prevent COVID-19 from causing victims among uninfected cancer patients?
2020-01-01 Ramella, S; Floreno, B; D'Angelillo, R M; Campanozzi, LAURA LEONDINA; Tambone, V
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine
2006-01-01 Trodella, L; D'Angelillo, Rm; Ramella, S; Cellini, F; Ciresa, M; Cesario, A; Granone, P
Chemoradiation for stage III non-small cell lung cancer
2013-01-01 Ramella, S; Fiore, M; Iurato, A; Trodella, Le; Trodella, L; D’Angelillo, Rm
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up | 1-gen-2020 | D'Angelillo, Rm; Fiore, M; Trodella, Le; Sciuto, R; Ippolito, E; Carnevale, A; Iurato, A; Miele, M; Trecca, P; Trodella, L; Greco, C; Ramella, S | |
| 42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis | 1-gen-2021 | Ramella, S.; Quattrocchi, C. C.; Ippolito, E.; Giordano, F. M.; Greco, C.; Mallio, C. A.; Santo, B.; D'Alessio, P.; Fiore, M.; D'Angelillo, R. M.; Zobel, B. Beomonte | |
| A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients | 1-gen-2014 | Ramella, S; Spoto, S; Fiore, M; Grasso, G; Campanale, Re; Ippolito, E; Greco, C; Iurato, A; Trodella, Le; Cortigiani, M; Trodella, L; D'Angelillo, Rm; Costantino, S | |
| A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer | 1-gen-2020 | Fiore, M; Taralli, S; Trecca, P; Scolozzi, V; Marinelli, L; Triumbari, Eka; Caputo, D; Angeletti, S; Ciccozzi, M; Coppola, A; Greco, C; Ippolito, E; Calcagni, Ml; Coppola, R; Ramella, S | |
| A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. | 1-gen-2016 | Arcangeli, S; Ramella, S; De Bari, B; Franco, P; Alongi, F; D'Angelillo, Rm. | |
| A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer | 1-gen-2022 | Caruso, C. M.; Guarrasi, V.; Cordelli, E.; Sicilia, R.; Gentile, S.; Messina, L.; Fiore, M.; Piccolo, C.; Beomonte Zobel, B.; Iannello, G.; Ramella, S.; Soda, P. | |
| A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation | 1-gen-2016 | Stimato, G; Ippolito, E; Silipigni, S; DI VENANZIO, C; Rinaldi, Cg; Gaudino, D; Fiore, M; Trodella, L; D’Angelillo, R; Ramella, S | |
| A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients | 1-gen-2018 | Ramella, S; Fiore, M; Greco, C; Cordelli, C; Sicilia, R; Merone, M; Molfese, E; Miele, M; Cornacchione, P; Ippolito, E; Iannello, G; D’Angelillo, Rm; Soda, P | |
| Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy | 1-gen-2010 | Ramella, S; Trodella, L; Mineo, Tc; Pompeo, E; Stimato, G; Gaudino, D; Valentini, V; Cellini, F; Ciresa, M; Fiore, M; Piermattei, A; Russo, P; Cesario, A; D'Angelillo, Rm | |
| Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial | 1-gen-2002 | Trodella, L; Granone, P; Valente, S; Valentini, V; Balducci, M; Mantini, G; Turriziani, A; Margaritora, S; Cesario, A; Ramella, S; Corbo, Gm; D'Angelillo, Rm; Fontana, A; Galetta, D; Cellini, N | |
| Application of a practical method for the isocenter point in vivo dosimetry by a transit signal | 1-gen-2007 | Piermattei, A; Fidanzio, A; Azario, L; Grimaldi, L; D'Onofrio, G; Cilla, S; Stimato, G; Gaudino, D; Ramella, S; D'Angelillo, R; Cellini, F; Trodella, L; Russo, A; Iadanza, L; Zucca, S; Fusco, V; DI NAPOLI, N; Gambacorta, Ma; Balducci, M; Cellini, N; Deodato, F; Macchia, G; Morganti, Ag | |
| Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? | 1-gen-2018 | D'Angelillo, Rm1; Ramella, S | |
| Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer | 1-gen-2004 | D'Angelillo, Rm; Trodella, L; Ramella, S | |
| Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis | 1-gen-2010 | Ramella, S; Trodella, L; Mineo, Tc; Pompeo, E; Gambacorta, Ma; Cellini, F; Ciresa, M; Fiore, M; Greco, C; Gaudino, D; Stimato, G; Piermattei, A; Cesario, A; D'Angelillo, Rm | |
| Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). | 1-gen-2018 | Imbimbo, M1; Ottaviano, M2; Vitali, M3; Fabbri, A4; Leuzzi, G5; Fiore, M6; Franceschini, D7; Pasello, G8; Perrino, M9; Schiavon, M10; Pruneri, G4; Dei Tos, Ap11; Sangalli, C12; Garassino, Mc3; Berardi, R13; Alessi, A14; Calareso, G15; Petrini, I16; Scorsetti, M17; Scotti, V18; Rosso, L19; Rea, F10; Pastorino, U5; Casali, Pg20; Ramella, S; Ricardi, U21; Abate-Daga, L22; Torri, V23; Trama, A24; Palmieri, G2; Marino, M25; Zucali, Pa9; TYME network, Collaborators. | |
| Bisphosphonates: molecular bases and clinical evidences | 1-gen-2011 | Orecchia, R; Ramella, S; Mandoliti, G; Trodella, L; Muto, P | |
| Breakthrough pain management in patients undergoing radiotherapy: a national survey on behalf of the Palliative and Supportive Care Study Group. | 1-gen-2015 | Caravatta, L; Ramella, S; Melano, A; Trippa, F; Santacaterina, A; Bacchiddu, S; Mandoliti, G; Mantini, G | |
| Can we prevent COVID-19 from causing victims among uninfected cancer patients? | 1-gen-2020 | Ramella, S; Floreno, B; D'Angelillo, R M; Campanozzi, LAURA LEONDINA; Tambone, V | |
| Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine | 1-gen-2006 | Trodella, L; D'Angelillo, Rm; Ramella, S; Cellini, F; Ciresa, M; Cesario, A; Granone, P | |
| Chemoradiation for stage III non-small cell lung cancer | 1-gen-2013 | Ramella, S; Fiore, M; Iurato, A; Trodella, Le; Trodella, L; D’Angelillo, Rm |